LobbyingQuva Pharma lobbying by quarter
Quva Pharma's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q3 2023; the issues it reports most are Pharmacy.
Quva Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$450K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE8 reports
- HOUSE OF REPRESENTATIVES7 reports
- Centers For Medicare and Medicaid Services (CMS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Van Scoyoc Associates | $310K | 7 quarters |
| Prime Policy Group | $250K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EMILY AUSTEN KATZ | Senior Health Policy Advisor, Senator Barbara Boxer; Health Policy Director, Representative Diana DeGette; Legislative Assistant, Senator Ron Wyden; and Legislative Aide, Senator Ron Wyden | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Van Scoyoc Associates | $50K |
| 04/17for Q1 | Van Scoyoc Associates | $50K |
| 01/19for Q4 2025 | Van Scoyoc Associates | $50K |
| 25/10/17for Q3 2025 | Van Scoyoc Associates | $50K |
| 25/07/18for Q2 2025 | Van Scoyoc Associates | $50K |
| 25/04/18for Q1 2025 | Van Scoyoc Associates | $40K |
| 25/01/20for Q4 2024 | Van Scoyoc Associates | $20K |
| 24/12/13for Q4 2024 | Van Scoyoc Associates | Under $5,000 |
| 24/10/14for Q3 2024 | Prime Policy Group | $50K |
| 24/07/19for Q2 2024 | Prime Policy Group | $50K |
| 24/04/17for Q1 2024 | Prime Policy Group | $50K |
| 24/01/18for Q4 2023 | Prime Policy Group | $50K |
| 23/10/20for Q3 2023 | Prime Policy Group | $50K |
| 23/10/19for Q3 2023 | Prime Policy Group | Under $5,000 |